Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Joe Turgeon
Recent Posts
Colombia Oil and Gas 2023 Congress – Status and Developments Prospects of Oil and Gas industry in Latin America
Mike The Pike Productions, Inc. (OTC: MIKP) Announces Virtual Shareholder Conference July 25, 2023
Künstliche Intelligenz im Kinderherz-Zentrum
Auri Inc. – Dividend, Retirement Timelines and Expectations
Auto Parts 4Less Group, Inc. Unveils Significant Business Progress and Future Plans in Latest Investor Update
Popular Post
-
Japanese Premier Declares COVID-19 State of Emergency in Tokyo
-
Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage
-
Expect Even More Unique Electric Cars Says Ferrari
-
Kimberly Goldwin Poised to Become Next President of ABC News
-
Records Show 19,000 U.S Based Amazon Employees Contracted Coronavirus
